Keywords: Biomarkers, biomarkers
Motivation: Monitoring the enzymatic activity of APN in tumors non-invasively can improve cancer diagnostics and therapy. A hyperpolarized AGN probe is a key biomarker for APN
Goal(s): This study aimed to validate the physiological characteristics of AGN probes in vivo
Approach: We used hyperpolarized 13C MRS and EPSI to measure APN activity in tumors with varying APN expression. DCE-MRI, DWI, and EPR imaging to evaluate several tumor physiological parameters
Results: The AGN probe distinguished high and low APN-expressing tumors, even in low permeability and hypoxic regions, showing promise for personalized cancer treatment
Impact: The hyperpolarized AGN probe provides a novel, non-invasive method for real-time monitoring of APN activity in tumors, even in hypoxic and low-perfusion regions, thus providing therapeutic strategies and personalized cancer treatment
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords